TrialBlood advances2024

Combination therapy with ruxolitinib and pegylated interferon alfa-2a in newly diagnosed patients with polycythemia vera.

Anders Lindholm Sørensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.